BioPlus Acquisition (BIOS) News Today → The Overlooked Retirement Asset You Probably Don’t Own (From Crypto 101 Media) (Ad) Free BIOS Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 14, 2024 | markets.businessinsider.comVerde Bio and SensaSure Technologies Complete Merger to Create Premier Mineral Acquisitions CompanyApril 16, 2024 | markets.businessinsider.comImugene and Kincell Bio Announce Strategic Manufacturing and Process Development PartnershipApril 3, 2024 | benzinga.comLouis G Lange's Net WorthFebruary 9, 2024 | msn.comWhy Intelligent Bio Solutions Stock Is Ripping HigherJanuary 22, 2024 | investing.comBioPlus Co Ltd (099430)October 4, 2023 | msn.comSPAC BioPlus, Avertix terminate merger; BioPlus to liquidateOctober 4, 2023 | markets.businessinsider.comAvertix, BIOS Acquisition Agree To Terminate Merger DealOctober 4, 2023 | finance.yahoo.comAvertix and BIOS Acquisition Corporation Mutually Agree to Terminate Proposed Business CombinationOctober 4, 2023 | finance.yahoo.comBioPlus Acquisition Corp. Announces Termination of Business Combination Agreement with Avertix Medical, Inc. and its Intention to LiquidateSeptember 29, 2023 | marketbeat.comShort Interest in BioPlus Acquisition Corp. (NASDAQ:BIOS) Declines By 36.0%BioPlus Acquisition Corp. (NASDAQ:BIOS - Get Free Report) was the target of a significant decline in short interest during the month of September. As of September 15th, there was short interest totalling 1,600 shares, a decline of 36.0% from the August 31st total of 2,500 shares. Based on an average daily trading volume, of 40,000 shares, the short-interest ratio is presently 0.0 days. Approximately 0.0% of the company's stock are short sold.August 18, 2023 | marketbeat.comWeiss Asset Management LP Raises Stock Holdings in BioPlus Acquisition Corp. (NASDAQ:BIOS)Weiss Asset Management LP raised its position in BioPlus Acquisition Corp. (NASDAQ:BIOS - Free Report) by 176.8% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 145,000 shares of the company's stock afterAugust 16, 2023 | finance.yahoo.comHeart & Rhythm Institute of Trinity and Avertix Announce Partnership to Improve Cardiac Care and Patient MonitoringAugust 16, 2023 | finance.yahoo.comAvertix Partners with Institute on Implantable Heart Attack Detection SystemJuly 20, 2023 | finance.yahoo.comAvertix Medical Welcomes Renown Cardiologist to Board of DirectorsJuly 17, 2023 | finance.yahoo.comRenown Cardiologist and Professor Ian T. Meredith, MD to Join Avertix Medical’s Board of DirectorsJune 15, 2023 | marketbeat.comRadcliffe Capital Management L.P. Increases Stake in BioPlus Acquisition Corp. (NASDAQ:BIOS)Radcliffe Capital Management L.P. grew its position in shares of BioPlus Acquisition Corp. (NASDAQ:BIOS - Get Rating) by 38.4% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 555,355 shares of the company's stock after buying an additionalJune 13, 2023 | finance.yahoo.comAvertix’s Guardian™ System, First and Only FDA-Approved Implantable Heart Attack Detection and Warning System, Now Available at AdventHealth OrlandoJune 9, 2023 | marketbeat.comRadcliffe Capital Management L.P. Boosts Stock Position in BioPlus Acquisition Corp. (NASDAQ:BIOS)Radcliffe Capital Management L.P. boosted its holdings in BioPlus Acquisition Corp. (NASDAQ:BIOS - Get Rating) by 38.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 555,355 shares of the company's stock afMay 26, 2023 | seekingalpha.comBIOS BioPlus Acquisition Corp.May 5, 2023 | msn.comSPAC BIOS to merge with cardiac device maker AvertixMay 3, 2023 | finance.yahoo.comAvertix, Maker of First and Only FDA-Approved Implantable Heart Attack Warning System, to Become Publicly Traded via Merger with BIOS Acquisition CorporationApril 24, 2023 | marketbeat.comBank of Montreal Can Trims Stock Holdings in BioPlus Acquisition Corp. (NASDAQ:BIOS)Bank of Montreal Can lessened its stake in shares of BioPlus Acquisition Corp. (NASDAQ:BIOS - Get Rating) by 31.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 236,746 shares of the company's stockApril 7, 2023 | marketbeat.comCalamos Advisors LLC Buys Shares of 1,000,000 BioPlus Acquisition Corp. (NASDAQ:BIOS)Calamos Advisors LLC purchased a new stake in BioPlus Acquisition Corp. (NASDAQ:BIOS - Get Rating) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 1,000,000 shares of the company's stock, valued at approximately $10,March 19, 2023 | marketbeat.comParallax Volatility Advisers L.P. Makes New Investment in BioPlus Acquisition Corp. (NASDAQ:BIOS)Parallax Volatility Advisers L.P. bought a new position in BioPlus Acquisition Corp. (NASDAQ:BIOS - Get Rating) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 221,829 shares of the company's stock, valued at approximately $2,226,000. ParallaMarch 18, 2023 | money.usnews.comBioPlus Acquisition Corp - Ordinary Shares - Class AMarch 14, 2023 | marketbeat.comMarshall Wace LLP Purchases 120,000 Shares of BioPlus Acquisition Corp. (NASDAQ:BIOS)Marshall Wace LLP raised its position in shares of BioPlus Acquisition Corp. (NASDAQ:BIOS - Get Rating) by 31.4% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 502,350 shares of the company's stock after acquiring an adMarch 10, 2023 | marketbeat.com221,829 Shares in BioPlus Acquisition Corp. (NASDAQ:BIOS) Acquired by Parallax Volatility Advisers L.P.Parallax Volatility Advisers L.P. bought a new position in shares of BioPlus Acquisition Corp. (NASDAQ:BIOS - Get Rating) during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor bought 221,829 shares of the company's stock, valued at approximately $December 14, 2022 | marketbeat.comBioPlus Acquisition Corp. (NASDAQ:BIOS) Sees Significant Increase in Short InterestBioPlus Acquisition Corp. (NASDAQ:BIOS - Get Rating) saw a large increase in short interest in the month of November. As of November 30th, there was short interest totalling 3,000 shares, an increase of 30.4% from the November 15th total of 2,300 shares. Based on an average daily volume of 51,600 shares, the days-to-cover ratio is presently 0.1 days. Approximately 0.0% of the shares of the company are sold short.December 1, 2022 | marketbeat.comBioPlus Acquisition Corp. (NASDAQ:BIOS) Sees Significant Growth in Short InterestBioPlus Acquisition Corp. (NASDAQ:BIOS - Get Rating) saw a large growth in short interest during the month of November. As of November 15th, there was short interest totalling 2,300 shares, a growth of 21.1% from the October 31st total of 1,900 shares. Based on an average daily trading volume, of 50,700 shares, the days-to-cover ratio is presently 0.0 days. Currently, 0.0% of the company's shares are sold short.November 16, 2022 | marketbeat.comShort Interest in BioPlus Acquisition Corp. (NASDAQ:BIOS) Declines By 9.5%BioPlus Acquisition Corp. (NASDAQ:BIOS - Get Rating) was the target of a significant drop in short interest during the month of October. As of October 31st, there was short interest totalling 1,900 shares, a drop of 9.5% from the October 15th total of 2,100 shares. Based on an average trading volume of 41,000 shares, the short-interest ratio is presently 0.0 days. Approximately 0.0% of the shares of the stock are sold short.September 23, 2022 | wsj.comBioPlus Acquisition Corp. Cl ASeptember 20, 2022 | finance.yahoo.comBioPlus Acquisition Corp. (BIOS)September 3, 2022 | investing.comBioPlus Acquisition Corp (BIOS)August 13, 2022 | reuters.comBioPlus Acquisition CorpAugust 10, 2022 | finance.yahoo.comWhat Type Of Shareholders Own The Most Number of BioPlus Acquisition Corp. (NASDAQ:BIOS) Shares? Get BioPlus Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for BIOS and its competitors with MarketBeat's FREE daily newsletter. Email Address Breaking News: Elon Musk Invents New Type of A.I. (Shocking) (Ad)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone. Click here for the full story… BIOS Media Mentions By Week BIOS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIOS News Sentiment▼0.001.15▲Average Unclassified News Sentiment BIOS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIOS Articles This Week▼10▲BIOS Articles Average Week Get BioPlus Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for BIOS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: KVAC News GHIX News MCAA News BRKH News IVCB News IVCA News TRIS News RENE News HCVI News EVE News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BIOS) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingDems have chosen Biden replacement?Paradigm PressA letter is coming from the "Bureau of the Fiscal Service".Stansberry ResearchThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsBill Clinton Backing Biden Replacement???The Freeport SocietyUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioPlus Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
